glutamic acid has been researched along with Leukemia, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, I; Ganor, Y; Goldstein, RS; Grinberg, I; Levite, M; Reis, A | 1 |
1 other study(ies) available for glutamic acid and Leukemia, T-Cell
Article | Year |
---|---|
Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Basigin; Cell Line, Tumor; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Antibody Technique; Glutamic Acid; Graft Survival; Green Fluorescent Proteins; Humans; Jurkat Cells; Leukemia, T-Cell; Matrix Metalloproteinase 9; Neoplasm Transplantation; Polymerase Chain Reaction; Receptors, AMPA; Transplantation, Heterologous | 2009 |